ALBERT DAVID
|
ALBERT DAVID Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -2.62 | 30.14 | 132.15 | 63.38 | 61.78 |
| CEPS(Rs) | 14.49 | 42.35 | 144.11 | 78.36 | 77.21 |
| DPS(Rs) | 5.00 | 5.00 | 11.50 | 9.00 | 9.00 |
| Book NAV/Share(Rs) | 686.04 | 687.70 | 671.05 | 545.93 | 489.68 |
| Tax Rate(%) | 384.76 | 31.82 | 22.48 | 28.70 | 25.45 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 1.62 | 0.85 | 12.25 | 12.33 | 12.38 |
| EBIT Margin(%) | 0.97 | 6.94 | 25.48 | 14.23 | 14.51 |
| Pre Tax Margin(%) | 0.15 | 6.79 | 25.37 | 14.07 | 14.30 |
| PAT Margin (%) | -0.42 | 4.63 | 19.67 | 10.03 | 10.66 |
| Cash Profit Margin (%) | 2.34 | 6.51 | 21.45 | 12.40 | 13.33 |
| Performance Ratios | |||||
| ROA(%) | -0.24 | 2.80 | 13.51 | 7.33 | 8.01 |
| ROE(%) | -0.38 | 4.44 | 21.72 | 12.24 | 13.46 |
| ROCE(%) | 0.83 | 6.55 | 27.87 | 17.10 | 18.10 |
| Asset Turnover(x) | 0.56 | 0.60 | 0.69 | 0.73 | 0.75 |
| Sales/Fixed Asset(x) | 1.39 | 1.54 | 1.70 | 1.62 | 1.52 |
| Working Capital/Sales(x) | 1.37 | 1.49 | 1.41 | 1.76 | 2.26 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.72 | 0.65 | 0.59 | 0.62 | 0.66 |
| Receivable days | 31.64 | 27.87 | 28.39 | 28.00 | 24.56 |
| Inventory Days | 63.07 | 52.84 | 44.87 | 45.48 | 41.36 |
| Payable days | 112.32 | 112.22 | 132.65 | 130.63 | 115.22 |
| Valuation Parameters | |||||
| PER(x) | - | 26.92 | 8.14 | 8.08 | 8.61 |
| PCE(x) | 40.52 | 19.16 | 7.46 | 6.53 | 6.89 |
| Price/Book(x) | 0.86 | 1.18 | 1.60 | 0.94 | 1.09 |
| Yield(%) | 0.85 | 0.62 | 1.07 | 1.76 | 1.69 |
| EV/Net Sales(x) | 0.99 | 1.36 | 1.61 | 0.80 | 0.92 |
| EV/Core EBITDA(x) | 25.07 | 14.40 | 5.59 | 4.54 | 5.10 |
| EV/EBIT(x) | 96.45 | 18.29 | 5.99 | 5.29 | 6.03 |
| EV/CE(x) | 0.79 | 1.17 | 1.52 | 0.86 | 0.61 |
| M Cap / Sales | 1.00 | 1.34 | 1.69 | 0.86 | 0.97 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -3.52 | -4.61 | 6.12 | 8.95 | 26.70 |
| Core EBITDA Growth(%) | -59.71 | -68.68 | 74.62 | 5.45 | 55.72 |
| EBIT Growth(%) | -86.70 | -73.62 | 90.41 | 6.98 | 69.94 |
| PAT Growth(%) | -108.69 | -77.19 | 108.49 | 2.60 | 59.23 |
| EPS Growth(%) | -108.69 | -77.19 | 108.49 | 2.60 | 59.23 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.07 | 0.03 | 0.01 | 0.02 | 0.02 |
| Current Ratio(x) | 2.11 | 2.15 | 2.33 | 2.09 | 1.81 |
| Quick Ratio(x) | 1.86 | 1.86 | 2.11 | 1.82 | 1.59 |
| Interest Cover(x) | 1.18 | 47.11 | 226.30 | 87.91 | 71.35 |
| Total Debt/Mcap(x) | 0.09 | 0.02 | - | 0.02 | 0.02 |
Compare Financial Ratios of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹393.5 Cr | -0.7% | -4% | -25% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0.7% |
-4% |
-25% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses
